3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
4
Leukemia
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Waldenstrom Macroglobulinemia
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Fallopian Tube Neoplasms
1
Congenital Abnormalities
1
Central Nervous System Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
21
Isotretinoin
14
Etoposide
13
Topotecan
12
Irinotecan
12
dinutuximab
10
Temozolomide
10
Magnetic Resonance Spectroscopy
10
Doxorubicin
10
Melphalan
9
sargramostim
8
Vincristine
8
Filgrastim
7
Cisplatin
7
Specimen Handling
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Granulocyte Colony-Stimulating Factor
6
Carboplatin
6
3-Iodobenzylguanidine
6
X-Rays
5
Phantoms, Imaging
5
Busulfan
5
Biopsy
5
fludarabine
4
etoposide phosphate
4
aldesleukin
4
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Neuroblastoma
×
IL32 protein, human
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts